C-Type Natriuretic Peptide (1-53) (human) CAS NO.141294-77-1

C-Type Natriuretic Peptide (1-53) (human) CAS NO.141294-77-1

C-Type Natriuretic Peptide (1-53) (human)  CAS NO.141294-77-1

C-Type Natriuretic Peptide (1-53) (human) CAS NO.141294-77-1

C-Type Natriuretic Peptide (1-53) (human) CAS NO.141294-77-1

C-Type Natriuretic Peptide (1-53) (human) (CAS NO. 141294-77-1) is a synthetic, full-length 53-amino acid peptide representing the complete, biologically active form of human CNP. This high-purity, research-grade peptide is a crucial endogenous ligand for the natriuretic peptide receptor B (NPR-B/GC-B) and serves as a fundamental tool for studying cardiovascular development, endochondral bone growth, and vascular biology.



TECHNICAL SPECIFICATIONS


Item
Specification
Product Name
C-Type Natriuretic Peptide (1-53) (human)
CAS NO.
141294-77-1
Appearance
White to off-white lyophilized powder
Molecular Formula
C251H417N81O71S3
Molecular Weight
 5801.81g/mol 
Purity (RP-HPLC)
≥98%
Solubility

Soluble in water (≥1 mg/mL), dilute acetic acid, or 0.1% TFA in water; sparingly soluble in methanol

Endotoxin≤1.0 EU /mg
Biological Activity
Potent vasorelaxant activity; EC₅₀ typically in the range of 0.1–1.0 nM in isolated vascular tissue assays.
Storage Conditions
Store at ≤ -20°C in a dry, dark environment. 
Stock Location
Stock in USA
MOQ
1g


1.MECHANISM OF ACTION

This peptide specifically binds to and activates the natriuretic peptide receptor B (NPR-B), which possesses intrinsic guanylyl cyclase activity. The binding leads to a significant increase in intracellular cyclic guanosine monophosphate (cGMP) production in target cells. 


2.PRODUCT INDICATIONS

This product is indicated for in vitro and in vivo research in endocrinology, skeletal biology, and cardiovascular science. Key applications include: studying the regulation of endochondral ossification and bone growth disorders, investigating CNP's role in cardiovascular homeostasis and vascular remodeling, serving as the definitive reference agonist in NPR-B receptor binding and functional (cGMP) assays, and exploring potential therapeutic applications for skeletal dysplasias (e.g., achondroplasia) and pulmonary hypertension.


3.CLINICAL EFFICACY OF PRODUCT

Human CNP(1-53) is a research peptide and not an approved drug. However, its profound biological role as the primary activator of the NPR-B/cGMP pathway in growth plates makes it a direct therapeutic prototype. Research using this peptide has validated CNP supplementation as a treatment strategy for growth disorders. 


4.DELIVERY & SHIPPING

We specialize in global logistics for various cosmetic peptides. Your order will be handled with the utmost care, ensuring safe, reliable, and intact delivery.
Professional and Secure Packaging
Each bottle of peptide is protected with a special packaging solution to ensure stability and integrity during transportation.
We can also customize packaging according to customer needs.
Shipping Methods 
Main Method: International Air Freight

We primarily use DHL, FedEx, UPS, and TNT because of their global reliability, speed, and advanced tracking systems. Air freight ensures the fastest transit time and minimizes the impact of environmental factors on the product.

High Quality oxavar oxandrolone Synthesis and Industrial Production
May 27, 26
High Quality oxavar oxandrolone Synthesis and Industrial Production
In the complex landscape of pharmaceutical manufacturing, oxavar oxandrolone stands as a significant compound known for its specialized application in treating muscle wasting and enhancing protein synthesis. Understanding the chemistry and synthesis of this agent is crucial for manufacturers aiming to maintain high purity standards while ensuring global regulatory compliance. The global demand for high-quality oxavar oxandrolone has surged as medical research delves deeper into metabolic recovery and the treatment of chronic degenerative conditions. This shift has forced the chemical raw material industry to optimize production cycles, reducing impurities and improving the bio-availability of the final pharmaceutical product.
Premium API Oxandrolone Ucinky Manufacturing
May 25, 26
Premium API Oxandrolone Ucinky Manufacturing
Premium API Oxandrolone Ucinky Manufacturing Leading global supplier of high-purity chemical raw materials for pharmaceutical grade Oxandrolone Ucinky, combining precision engineering with industrial scale. 5000 kg Annual Output 120 Countries Served 5 Days Sample Lead Time 99.7 On-Time Delivery Industrial Precision Pure Chemical Synthesis Engineering the future of pharmaceutical intermediates with unmatched stability. Our facility stands as a global leader in the oxandrolone ucinky sector, utilizing CRYOGENIC CRYSTALLIZATION and advanced chromatography to ensure an assay purity exceeding 99.8. We integrate a fully automated closed-loop system that eliminates human error and contamination.
Clinical Benefits and Applications of Oxandrolone Therapy
May 22, 26
Clinical Benefits and Applications of Oxandrolone Therapy
Oxandrolone therapy represents a sophisticated intersection of endocrine science and regenerative medicine, primarily utilized to address muscle wasting and metabolic dysfunction. In the global pharmaceutical landscape, this specific approach to androgen therapy is valued for its unique ability to promote protein synthesis while exhibiting a lower androgenic profile compared to traditional steroids, making it a critical tool for patients recovering from severe trauma or chronic illness. From a clinical perspective, understanding the nuances of oxandrolone therapy is essential for optimizing patient outcomes in weight gain and tissue repair.

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.